Corporate GovernanceJun 17, 2026, 04:07 PM
Inmune Bio Stockholders Approve Amended Incentive Plan, Elect Directors
AI Summary
Inmune Bio, Inc. stockholders approved the Third Amended and Restated 2021 Stock Incentive Plan at their annual meeting on June 16, 2026. The plan increases the shares reserved for awards from 6,500,000 to 9,158,525 and includes an evergreen provision for future automatic increases. Additionally, stockholders elected five directors and ratified CBIZ CPAs P.C. as the independent auditors for fiscal year 2026.
Key Highlights
- Stockholders approved the Third Amended and Restated 2021 Stock Incentive Plan.
- Shares reserved under the plan increased from 6,500,000 to 9,158,525.
- An evergreen provision was approved for annual share increases (up to 10% of outstanding shares) from 2027-2031.
- Five directors were elected: David Moss, J. Kelly Ganjei, Tim Schroeder, Scott Juda, JD, and Marcia Allen.
- CBIZ CPAs P.C. was ratified as the independent auditor for fiscal year 2026.
Price Impact
More from INMB